Waiv alternatives and competitors
The closest alternatives to Waiv are Stratipath, PreciseDx, Panakeia Technologies and Mindpeak.
Waiv sells AI tests that read routine H&E slides, for pathology laboratories and oncology teams in Europe, and biomarker services for drug developers.
10 alternatives to Waiv
What each product does, with its price as the vendor publishes it.
-
S
Stratipath Breast assigns early stage invasive breast cancers to low or high risk groups from routine H&E slides, as a faster, cheaper alternative to gene expression tests for pathology laboratories and breast cancer teams in Europe.
Price: No published price
-
P
PreciseDx sells PreciseBreast, a test that predicts whether early breast cancer will come back, using AI to read the cell patterns on a routine stained slide.
Price: No published price
-
P
Panakeia infers molecular status from routine H&E slide images, without sequencing, immunohistochemistry or additional tissue.
Price: No pricing published; clinical products and research platform both quoted, unit of charge unstated
-
M
Mindpeak sells AI that scores cancer biomarkers on pathology slides, which laboratories use to quantify HER2, ER, PR, Ki-67 and PD-L1 on immunohistochemistry and H&E images.
Price: No published price
-
I
Ibex sells AI applications that read H&E whole slide images for prostate, breast and gastric cancer and return their findings into laboratories' existing image management and laboratory systems, through partners including Roche, Philips, Proscia, Sectra and Fujifilm.
Price: No published price
-
T
Tribun Health sells CaloPix, software that pathology laboratories use to manage cases and review scanned slides on screen.
Price: No published price
-
V
Visiopharm sells pathology image analysis software for diagnostics and research, with its diagnostic products packaged as APPs: deep learning algorithms that score HER2, Ki67, ER and PR and detect metastases in breast cancer, score PD-L1 in non-small cell lung cancer, and assess prostate…
Price: No published price
-
A
Aiforia sells cloud based deep learning image analysis that pathology laboratories use for cancer diagnostics and that researchers use for preclinical work.
Price: No published price
-
I
Imagene AI reads routine stained lung cancer slides and predicts which gene changes a tumor carries, without using more tissue for sequencing.
Price: No published price
-
L
Lunit SCOPE is the pathology AI line of Lunit, the Seoul medical AI company. Drug companies, contract research organizations and digital pathology platforms use it to measure cancer biomarkers on tissue slides for research and trials.
Price: No published price
Waiv alternatives, answered
What are the best alternatives to Waiv?
The closest alternatives to Waiv are Stratipath, PreciseDx, Panakeia Technologies, Mindpeak and Ibex Medical Analytics. Stratipath Breast assigns early stage invasive breast cancers to low or high risk groups from routine H&E slides, as a faster, cheaper alternative to gene expression tests for pathology laboratories and breast cancer teams in Europe. PreciseDx sells PreciseBreast, a test that predicts whether early breast cancer will come back, using AI to read the cell patterns on a routine stained slide. Panakeia infers molecular status from routine H&E slide images, without sequencing, immunohistochemistry or additional tissue.
Who are Waiv's competitors?
Waiv's competitors in the Digital Pathology AI category include Stratipath, PreciseDx, Panakeia Technologies, Mindpeak, Ibex Medical Analytics and Tribun Health.